TAC Cancer Research Results
TAC, total antioxidant capacity: Click to Expand ⟱
| Source: |
| Type: |
Total antioxidant capacity (TAC) refers to the ability of a biological sample (such as blood, tissues, or food) to counteract oxidative stress by neutralizing free radicals and reactive oxygen species (ROS).
May have reduced levels in cancers.
|
Scientific Papers found: Click to Expand⟱
ROS↑, Apoptosis↑, Bax:Bcl2↑, VEGF↑, Akt↓, PI3K↓, TAC↓, TOS↑, OSI↑, MDA↑, Casp3↑, Casp7↑,
tumCV↓, ROS↑, MMP↓, TumCMig↓, TAC↓, lipid-P↓, NF-kB↓, Apoptosis↑,
| - |
in-vitro, |
GBM, |
U87MG |
|
|
|
- |
in-vivo, |
Nor, |
HaCaT |
|
|
|
TOS↑, TumCG↓, MDA↑, SOD↑, Catalase↑, TAC↓, GSH↓, BRAF↑, MAPK↓, PTEN↓, Raf↓, *toxicity↓,
*AntiCan↑, *Bacteria↓, *AntiViral↑, *antiD↓, *RenoP↑, *hepatoP↑, *eff↑, *Sepsis↓, *AntiArt↑, *Stroke↓, TumCMig↓, TumCI↓, MTA1↓, TIMP2↓, MMP2↓, MMP↓, Cyt‑c↑, Akt↓, mTOR↓, P70S6K↓, TumAuto↑, PD-L1↓, TNF-α↓, IL1β↓, IL6↓, IL8↓, Bcl-2↓, Bcl-xL↓, BAX↑, BAD↑, Bak↑, VEGF↓, Casp3↑, Casp8↑, P53↑, GSH↓, SOD↓, Catalase↓, TAC↓, XIAP↓, ROS↓, NF-kB↓, TLR4↓, P-gp/ABCB1↓, LRP1↓, Fas↑, p27/CDKN1B↑, *cardioP↑, *AntiThr↑, *PAI-1/SERPINE1↓, *BUN↓, *ALAT↓, *AST↓, *neuroP?,
Showing Research Papers: 1 to 4 of 4
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 4
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
MTA1↓, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
Catalase↓, 1, Catalase↑, 1, GSH↓, 2, lipid-P↓, 1, MDA↑, 2, OSI↑, 1, ROS↓, 1, ROS↑, 2, SOD↓, 1, SOD↑, 1, TAC↓, 4, TOS↑, 2,
Mitochondria & Bioenergetics(tgid=3) ⓘ
MMP↓, 2, Raf↓, 1, XIAP↓, 1,
Cell Death(tgid=5) ⓘ
Akt↓, 2, Apoptosis↑, 2, BAD↑, 1, Bak↑, 1, BAX↑, 1, Bax:Bcl2↑, 1, Bcl-2↓, 1, Bcl-xL↓, 1, Casp3↑, 2, Casp7↑, 1, Casp8↑, 1, Cyt‑c↑, 1, Fas↑, 1, MAPK↓, 1, p27/CDKN1B↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
tumCV↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
TumAuto↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
P53↑, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
BRAF↑, 1, mTOR↓, 1, P70S6K↓, 1, PI3K↓, 1, PTEN↓, 1, TumCG↓, 1,
Migration(tgid=13) ⓘ
LRP1↓, 1, MMP2↓, 1, TIMP2↓, 1, TumCI↓, 1, TumCMig↓, 2,
Angiogenesis & Vasculature(tgid=14) ⓘ
VEGF↓, 1, VEGF↑, 1,
Barriers & Transport(tgid=15) ⓘ
P-gp/ABCB1↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IL1β↓, 1, IL6↓, 1, IL8↓, 1, NF-kB↓, 2, PD-L1↓, 1, TLR4↓, 1, TNF-α↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
BRAF↑, 1, IL6↓, 1, PD-L1↓, 1,
Total Targets: 58
Pathway results for Effect on Normal Cells:
NA, unassigned(tgid=0) ⓘ
AntiArt↑, 1, antiD↓, 1, Stroke↓, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 1, BUN↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
AntiThr↑, 1,
Migration(tgid=13) ⓘ
PAI-1/SERPINE1↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 1, AST↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 1, cardioP↑, 1, hepatoP↑, 1, neuroP?, 1, RenoP↑, 1, toxicity↓, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiViral↑, 1, Bacteria↓, 1, Sepsis↓, 1,
Total Targets: 19
Scientific Paper Hit Count for: TAC, total antioxidant capacity
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:626 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid
Home Page